Literature DB >> 23168063

The imaging of pulmonary hypertension.

Aletta Ann Frazier1, Allen P Burke.   

Abstract

Pulmonary hypertension (PH) is the remarkable hemodynamic consequence of widespread structural and functional changes within the pulmonary circulation. Elevated pulmonary vascular resistance leads to increased mean pulmonary arterial pressure and, ultimately, right ventricular dysfunction. PH carries a poor prognosis and warrants timely and accurate diagnosis for appropriate intervention. The 2008 Dana Point classification system provides the categorical framework currently guiding therapy and surveillance. Radiologic imaging is an essential tool in the detection and diagnostic evaluation of patients with PH. Echocardiography, ventilation-perfusion scintigraphy, multidetector computed tomography, and cardiac magnetic resonance imaging provide insights into vascular morphology, pulmonary parenchymal status, cardiac function, and underlying etiology of the disorder. Emerging techniques of functional pulmonary and cardiac imaging hold great promise for the assessment and monitoring of these patients in the future.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23168063     DOI: 10.1053/j.sult.2012.06.002

Source DB:  PubMed          Journal:  Semin Ultrasound CT MR        ISSN: 0887-2171            Impact factor:   1.875


  10 in total

Review 1.  Imaging in congenital pulmonary vein anomalies: the role of computed tomography.

Authors:  Kevin Todd Dyer; Anthony Marcus Hlavacek; Felix Gabriel Meinel; Carlo Nicola De Cecco; Andrew Douglas McQuiston; Uwe Joseph Schoepf; Nicholas Peter Pietris
Journal:  Pediatr Radiol       Date:  2014-08-21

2.  Modulating the dysregulated migration of pulmonary arterial hypertensive smooth muscle cells with motif mimicking cell permeable peptides.

Authors:  Jamie L Wilson; Chamila Rupasinghe; Anny Usheva; Rod Warburton; Chloe Kaplan; Linda Taylor; Nicholas Hill; Dale F Mierke; Peter Polgar
Journal:  Curr Top Pept Protein Res       Date:  2015

Review 3.  Imaging of pulmonary hypertension: an update.

Authors:  Harold Goerne; Kiran Batra; Prabhakar Rajiah
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

Review 4.  High-resolution computed tomographic findings of cocaine-induced pulmonary disease: a state of the art review.

Authors:  Renata Rocha de Almeida; Luciana Soares de Souza; Alexandre Dias Mançano; Arthur Soares Souza; Klaus Loureiro Irion; Luiz Felipe Nobre; Gláucia Zanetti; Bruno Hochhegger; Jorge Luiz Pereira e Silva; Edson Marchiori
Journal:  Lung       Date:  2014-01-16       Impact factor: 2.584

5.  Right ventricular end-systolic remodeling index on cardiac magnetic resonance imaging: comparison with other functional markers in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Ling Zhang; Jinzhu Dai; Peiyao Zhang; Haiyi Ma; Xincao Tao; Yanan Zhen; Xiaopeng Liu; Wanmu Xie; Jun Wan; Min Liu
Journal:  Quant Imaging Med Surg       Date:  2022-02

6.  Hyperplastic Growth of Pulmonary Artery Smooth Muscle Cells from Subjects with Pulmonary Arterial Hypertension Is Activated through JNK and p38 MAPK.

Authors:  Jamie L Wilson; Jun Yu; Linda Taylor; Peter Polgar
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

7.  Mosaic Pattern of Lung Attenuation on Chest CT in Patients with Pulmonary Hypertension.

Authors:  Kamonpun Ussavarungsi; Augustine S Lee; Charles D Burger
Journal:  Diseases       Date:  2015-09-07

Review 8.  A review of imaging modalities in pulmonary hypertension.

Authors:  Mona Ascha; Rahul D Renapurkar; Adriano R Tonelli
Journal:  Ann Thorac Med       Date:  2017 Apr-Jun       Impact factor: 2.219

9.  Looking beyond the thrombus: essentials of pulmonary artery imaging on CT.

Authors:  Mohammed M Khadir; Apeksha Chaturvedi; Mike S Nguyen; John C Wandtke; Susan Hobbs; Abhishek Chaturvedi
Journal:  Insights Imaging       Date:  2014-07-08

10.  Unraveling endothelin-1 induced hypercontractility of human pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension.

Authors:  Jamie L Wilson; Rod Warburton; Linda Taylor; Deniz Toksoz; Nicholas Hill; Peter Polgar
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.